Neoadjuvant modified FOLFIRINOX followed by postoperative gemcitabine in borderline resectable pancreatic adenocarcinoma: a Phase 2 study for clinical and biomarker analysis

British Journal of Cancer, Published online: 20 May 2020; doi:10.1038/s41416-020-0867-xNeoadjuvant modified FOLFIRINOX followed by postoperative gemcitabine in borderline resectable pancreatic adenocarcinoma: a Phase 2 study for clinical and biomarker analysis
Source: British Journal of Cancer - Category: Cancer & Oncology Authors: Source Type: research